Glacier develops AI-enabled recycling robots for recycling facilities. Founded in 2019 and headquartered in San Francisco, California, the company creates affordable, high-performing, and space-efficient robots that automate the sorting of recyclable materials. Its platform combines artificial intelligence-powered sensors and robotics to streamline operations, improve sorting accuracy, and increase profitability for waste facilities.
Plaid
Venture Round in 2025
Plaid is a technology platform that provides APIs and developer tools to connect consumer bank accounts and financial data with applications. It enables developers to build modern financial services by offering infrastructure and intelligence tools that allow access to transactions, authentication for bank accounts, identity verification, real-time balances, asset verification, and income data. Its products include Transactions, Auth, Identity, Balance, Assets, and Income, supporting personal finance, consumer payments, lending, banking and brokerage, and business finance solutions. Plaid serves developers from startups to large financial institutions, helping democratize financial services with a developer-friendly experience. The company was founded in 2012 and is headquartered in San Francisco, California.
Vori Health
Series B in 2025
Vori Health offers an integrated medical practice specializing in treating musculoskeletal conditions. Its nationwide, evidence-based approach addresses back, neck, and joint issues through a unique, virtual-first care model. Patients are connected to a collaborative team consisting of a board-certified physician, health coach navigator, and physical therapist for comprehensive care.
Abcuro develops immunotherapies targeting autoimmunity and cancer. Founded in 2015, the company uses bioinformatics and ex-vivo validation to uncover novel immune system targets.
Instabase
Series D in 2025
Instabase, Inc. is a technology company based in San Francisco, California, founded in 2015. It specializes in developing a platform that automates document processing workflows and analyzes unstructured data. The platform integrates various capabilities, including optical character recognition, data classification and extraction, and natural language processing, allowing organizations across sectors such as insurance, finance, and healthcare to streamline operations and improve decision-making. Additionally, Instabase provides a developer kit that enables the creation of customized business applications, helping institutions embed artificial intelligence into their systems and processes. Through its innovative solutions, Instabase aims to address significant business challenges and facilitate transformational outcomes for its clients.
Outrider develops autonomous electric trucks and management software for logistics hubs. Its technology automates yard operations, enhancing safety and efficiency for large enterprises.
Second Front Systems
Series C in 2024
Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.
Moximed develops and provides the Atlas System, an implantable joint unloader designed to alleviate pain and preserve mobility in patients with medial compartment knee osteoarthritis. Its outpatient treatment option aims to improve quality of life for those not responsive to other therapies or candidates for knee replacement.
PayZen is a healthcare fintech company that helps patients manage out-of-pocket medical expenses by offering flexible, transparent payment plans and non-recourse financing. The platform enables patients to pay bills over time while helping providers accelerate cash flow and reduce costly collections. It uses AI-powered risk assessment to tailor each plan to the individual patient, supporting affordable payments without upfront burden. Founded in 2019 in San Francisco by Ariel Rosenthal, Itzik Cohen, and Tobias Mezger, PayZen aims to reduce financial barriers to care while enabling providers to focus on delivering services.
MBX Biosciences
Series C in 2024
MBX Biosciences is a biotechnology company focused on developing therapies for endocrine and metabolic disorders, emphasizing rare endocrine diseases with limited treatment options. It pursues discovery, development, and commercialization of first-in-class peptide therapeutics that modulate glandular hormone signaling. MBX has developed a proprietary Precision Endocrine Peptide platform to engineer peptides with extended time-action profiles and consistent drug exposure, aiming to overcome limitations of traditional peptide therapies and improve disease management. Based in Carmel, Indiana, the company advances novel peptide programs through clinical development to address unmet medical needs in endocrine and metabolic disorders.
Cardurion Pharmaceuticals
Series B in 2024
Cardurion Pharmaceuticals, LLC, established in 2017 and headquartered in Boston, Massachusetts, is a biotechnology company dedicated to developing innovative therapies for heart failure and other cardiovascular diseases. The company is advancing clinical programs that target PDE9 and CaMKII inhibition, utilizing its expertise in cardiovascular signaling pathways to address significant unmet patient needs.
Zenas BioPharma
Series C in 2024
Zenas BioPharma is a clinical-stage biopharmaceutical company focused on developing immune-based therapies for autoimmune and immune-mediated diseases. Based in Florida, United States, the company advances biologic programs and aims to modulate B cell–driven pathology. Its lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb on B cells, thereby inhibiting harmful immune activity without depleting B cells.
SafeBase, Inc. is a San Francisco-based company founded in 2020 that specializes in cloud-based security software aimed at helping organizations establish and enhance their security programs. The company’s offerings include a smart trust center platform that facilitates the sharing of security posture and automates access to sensitive documents. SafeBase provides solutions such as SafeBase Inspected, which features a website badge linking to a custom security status page, as well as custom security checklists and continuous monitoring of security systems. Additionally, the software assists organizations in configuring security policies, thereby enabling them to implement robust security practices effectively.
Xaira Therapeutics
Venture Round in 2024
Xaira Therapeutics is a biotechnology company that leverages artificial intelligence to revolutionize drug discovery and development. Headquartered in the San Francisco Bay Area, Xaira brings together machine learning experts, expansive data generation, and robust therapeutic product development to advance treatments for various diseases.
Korro Bio Inc., established in 2018 and headquartered in Cambridge, Massachusetts, specializes in developing nucleic acid-based therapeutics targeting specific sequences in genetic code to treat rare diseases. The company's proprietary platform enables efficient and selective RNA editing, leveraging natural processes common to all multicellular organisms. Korro Bio aims to advance this technology to effect changes in protein structure and function across multiple tissues, expanding the reach of genetic medicines with additional precision and tunability by editing RNA instead of DNA.
Lily AI is an innovative e-commerce product discovery platform based in Mountain View, California, that focuses on enhancing the sales performance of brands and retailers. The company specializes in integrating customer-centric product attributes into various facets of the e-commerce ecosystem, including site search engines and recommendation systems. By aligning brand messaging with customer intent, Lily AI improves on-site search, personalized product discovery, and demand prediction. This approach enables retailers, particularly in the fashion, home, and beauty sectors, to achieve significant increases in traffic, conversion rates, revenue, and brand loyalty.
Regulus Therapeutics
Post in 2024
Regulus Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of microRNA-targeted therapies for various diseases. Founded in 2007 and headquartered in San Diego, California, the company focuses on innovative treatments for conditions such as kidney diseases and viral infections. Its lead product candidates include RG-012, an anti-miR targeting miR-21, currently in Phase II clinical trials for Alport syndrome, and RGLS4326, an anti-miR targeting miR-17, which is undergoing Phase Ib clinical trials for autosomal dominant polycystic kidney disease. Additionally, Regulus is advancing a pipeline of preclinical drug candidates, including RGLS5579 to inhibit miR-10b, as well as programs aimed at treating Hepatitis B virus and Non-Alcoholic Steatohepatitis. The company's work leverages the recent scientific advancements in microRNA research, which play a crucial role in regulating gene expression.
Glacier
Venture Round in 2024
Glacier develops AI-enabled recycling robots for recycling facilities. Founded in 2019 and headquartered in San Francisco, California, the company creates affordable, high-performing, and space-efficient robots that automate the sorting of recyclable materials. Its platform combines artificial intelligence-powered sensors and robotics to streamline operations, improve sorting accuracy, and increase profitability for waste facilities.
Second Front Systems
Venture Round in 2024
Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.
VAST Data
Series E in 2023
VAST Data, Inc. is a technology company that specializes in developing innovative data storage solutions. Headquartered in New York, with additional offices in San Jose, California, the company offers a universal storage platform that utilizes Intel’s Optane SSDs as a cache for data stored on quad-level cell (QLC) SSDs. VAST Data's solutions cater to various sectors, including animation and visual effects, deep learning, life sciences, media and broadcasting, and enterprise backup and recovery. The platform is designed to enhance productivity, streamline data management, and accelerate time-to-insight for workload-intensive applications, making it particularly valuable for AI-driven organizations. Founded in 2016, VAST Data has rapidly established itself as a leading player in the data infrastructure market.
Second Front Systems
Series B in 2023
Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.
Transfix, Inc. is a trucking brokerage firm based in New York, specializing in connecting shippers with carriers for freight transportation across the United States. Founded in 2010, the company has developed an advanced online freight management platform that utilizes AI-driven algorithms to optimize freight matching and enhance supply chain visibility. Transfix offers real-time shipment tracking, alerts, and insights on carrier performance, ensuring efficient and reliable transportation solutions. The company serves a diverse range of industries, including retail, food, beverage, and manufacturing, focusing on creating a sustainable freight ecosystem while minimizing empty miles and improving operational efficiency. Through its Intelligent Freight Platform, Transfix aims to revolutionize supply chain performance and support organizations in achieving their logistics goals.
Mojo Vision
Series A in 2023
Founded in 2015, Mojo Vision specializes in developing and commercializing advanced micro-LED display technology for various applications. The company is renowned for creating the world's smallest dynamic display for augmented reality smart contact lenses. Headquartered in Saratoga, California, Mojo Vision aims to disrupt the $160 billion display industry with its proprietary quantum-dot technology.
Pair Eyewear
Series C in 2023
Pair Eyewear, Inc. is a New York-based company that specializes in customizable eyeglasses for children. Founded in 2017 by Nathan Kondamuri and Sophia Edelstein, the company offers a unique approach to eyewear by providing base frames and interchangeable top frames that allow kids to express their personal style and interests. By combining functionality with creativity, Pair Eyewear transforms glasses from mere medical devices into a fun and engaging accessory for children. The company's direct-to-consumer model leverages an e-commerce platform, making the purchasing process convenient for parents while enhancing the overall experience for young wearers. Pair Eyewear is committed to offering quality, affordable glasses that are both stylish and practical, featuring hand-polished frames and shatterproof polycarbonate lenses.
Pulumi Corporation
Series C in 2023
Founded in 2017, Pulumi Corporation operates an infrastructure-as-code platform for developing cloud software. It offers Pulumi SDK, an open-source tool enabling developers to create, deploy, and manage cloud applications and infrastructure using code. The company also provides a web console for collaborative delivery and management of cloud apps and infrastructure across public, private, or hybrid environments.
Gossamer Bio is a clinical-stage biopharmaceutical company based in San Diego that specializes in the discovery, development, and commercialization of innovative therapeutic products targeting significant unmet medical needs. Founded by former executives from Receptos, the company focuses on areas such as immunology, inflammation, fibrosis, and oncology. Its pipeline includes several promising candidates: Seralutinib, aimed at addressing pulmonary arterial hypertension; GB004, for inflammatory bowel disease; GB1275, targeting various oncology indications; and GB001, designed for moderate-to-severe eosinophilic asthma. Gossamer Bio's strategy involves leveraging a rich in-licensing environment to enhance its therapeutic offerings, supported by a team recognized for their successful track record in drug development.
Instabase
Series C in 2023
Instabase, Inc. is a technology company based in San Francisco, California, founded in 2015. It specializes in developing a platform that automates document processing workflows and analyzes unstructured data. The platform integrates various capabilities, including optical character recognition, data classification and extraction, and natural language processing, allowing organizations across sectors such as insurance, finance, and healthcare to streamline operations and improve decision-making. Additionally, Instabase provides a developer kit that enables the creation of customized business applications, helping institutions embed artificial intelligence into their systems and processes. Through its innovative solutions, Instabase aims to address significant business challenges and facilitate transformational outcomes for its clients.
Strive Health
Series C in 2023
Strive Health, LLC is a company focused on providing comprehensive solutions for chronic kidney disease. Founded in 2018 and based in Denver, Colorado, Strive Health operates dialysis centers and employs advanced predictive analytics to enhance patient care. The company offers a high-touch, technology-enabled clinical model that supports patients throughout their healthcare journey, from primary care engagement to dialysis treatment. By utilizing comparative and predictive data, Strive Health aims to identify at-risk patients and transform the management of kidney disease, promoting earlier intervention and increasing the adoption of home dialysis. This innovative approach not only improves patient outcomes but also seeks to reduce inpatient utilization, ultimately enhancing the overall experience for individuals dealing with chronic kidney conditions.
Sundeck
Seed Round in 2023
Founded in 2022, Sundeck is a Santa Clara-based company specializing in data infrastructure and analytics. It offers a platform that customizes Snowflake's behavior for every query, providing features such as warehouse optimization, adaptive controls, cost management, and new query syntax.
Regulus Therapeutics
Post in 2023
Regulus Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of microRNA-targeted therapies for various diseases. Founded in 2007 and headquartered in San Diego, California, the company focuses on innovative treatments for conditions such as kidney diseases and viral infections. Its lead product candidates include RG-012, an anti-miR targeting miR-21, currently in Phase II clinical trials for Alport syndrome, and RGLS4326, an anti-miR targeting miR-17, which is undergoing Phase Ib clinical trials for autosomal dominant polycystic kidney disease. Additionally, Regulus is advancing a pipeline of preclinical drug candidates, including RGLS5579 to inhibit miR-10b, as well as programs aimed at treating Hepatitis B virus and Non-Alcoholic Steatohepatitis. The company's work leverages the recent scientific advancements in microRNA research, which play a crucial role in regulating gene expression.
SimpleRose
Venture Round in 2023
SimpleRose Inc. is a technology company based in Saint Louis, Missouri, that specializes in developing a prescriptive analytics platform aimed at enhancing decision-making in complex environments. Founded in 2018, the company offers solutions that optimize and accelerate processes such as scheduling, production planning, and portfolio optimization. By leveraging advanced algorithmic innovations, SimpleRose’s platform provides high levels of numerical accuracy, speed, and the capability for continuous analysis, enabling organizations to effectively address operational challenges and make informed decisions.
Mojo Vision
Series C in 2023
Founded in 2015, Mojo Vision specializes in developing and commercializing advanced micro-LED display technology for various applications. The company is renowned for creating the world's smallest dynamic display for augmented reality smart contact lenses. Headquartered in Saratoga, California, Mojo Vision aims to disrupt the $160 billion display industry with its proprietary quantum-dot technology.
Relievant Medsystems
Venture Round in 2023
Relievant Medsystems, Inc. is a medical device company focused on developing innovative solutions for chronic axial low back pain. Founded in 2004 and headquartered in Minneapolis, Minnesota, with a development office in Sunnyvale, California, the company has created the Intracept System. This minimally invasive procedure specifically targets the basivertebral nerve, providing relief by blocking pain signal transmission. The Intracept System offers patients a low-risk therapy option aimed at alleviating chronic vertebrogenic low back pain.
Founded in 2021, OP3N is a global Web3 superapp that serves as a one-stop-shop for communication, connection, and commerce with on-chain interactions. It aims to create a more frictionless, decentralized, and democratized creator economy by consolidating tools needed for minting, sharing, and engaging with digital goods and tokens into one unified interface. Co-led by Jaeson Ma and Eric Tu, OP3N is headquartered in Los Angeles.
Fabric8Labs
Series B in 2023
Fabric8Labs, Inc. is a technology company founded in 2015 and located in La Jolla, California, specializing in non-thermal metal 3D printing. The company has developed a proprietary process that combines stereo-lithography and electro-deposition, providing an innovative alternative to traditional powder bed fusion technologies. This method eliminates the reliance on metal powders, vacuum chambers, and lasers, which significantly reduces manufacturing costs while enhancing material quality. Fabric8Labs' technology allows clients to use cartridges that simplify the additive manufacturing process and facilitate the safe disposal of used salt cartridges, thereby promoting efficiency and sustainability in metal 3D printing.
Crowdbotics
Series B in 2023
Crowdbotics is an application development platform that provides an enterprise-grade solution for building, modernizing and deploying web and mobile applications. It offers a library of production-grade components and a network of on-call experts to help product managers translate ideas into working code, selecting effective components and workflows. The platform handles infrastructure, implementation, maintenance, operations, monitoring and security for the life of a project, and uses artificial intelligence to map application requirements to existing code modules while capturing business logic and developer intent. It supports modernization, onboarding and governance by integrating with current tools and infrastructure, enabling enterprises to modernize legacy systems, reduce development risk and improve engineering efficiency.
Outrider develops autonomous electric trucks and management software for logistics hubs. Its technology automates yard operations, enhancing safety and efficiency for large enterprises.
SetPoint Medical Corporation
Venture Round in 2023
SetPoint Medical Corporation is a clinical-stage medical device company developing implantable neuromodulation therapies to treat chronic inflammatory and autoimmune diseases. Its platform uses vagus nerve stimulation to activate the body's inflammatory reflex, aiming to produce a systemic immune-restorative effect and offer an alternative to drug therapy for conditions such as rheumatoid arthritis and inflammatory bowel disease. Based in Valencia, California.
Minerva Surgical
Post in 2022
Minerva Surgical Inc. is a medical technology company based in Redwood City, California, dedicated to women's healthcare. Founded in 2008, the company specializes in developing, manufacturing, and commercializing minimally invasive solutions for uterine health. Its flagship product, the Minerva Endometrial Ablation System, is designed to treat abnormal uterine bleeding, a common issue affecting many women. Minerva Surgical offers a comprehensive range of alternatives to hysterectomy, aiming to address the underlying causes of abnormal uterine bleeding while preserving the uterus. These solutions are applicable in various medical environments and seek to overcome the limitations of traditional treatment methods, providing women with effective and less invasive options for their healthcare needs.
Gladly
Venture Round in 2022
Gladly, established in 2014 and headquartered in San Francisco, specializes in cloud-based software for contact centers serving B2C brands. Its platform enables seamless, omnichannel customer communication across voice, email, messaging, chat, and social media, empowering agents and fostering customer loyalty through positive experiences.
Escient Pharmaceuticals
Series C in 2022
Escient Pharmaceuticals, Inc. is a biotechnology company based in San Diego, California, specializing in the development and manufacture of G protein-coupled receptor (GPCR)-targeted drugs aimed at treating neuro-immuno-inflammatory and autoreactive diseases. Founded in 2017, Escient focuses on harnessing the therapeutic potential of specific orphan GPCRs, particularly the Mas-Related G-Protein Receptors (Mrgprs). The company aims to provide innovative therapies for a variety of conditions, including mast cell-mediated disorders and cholestatic pruritus, thereby expanding treatment options for healthcare providers facing these complex diseases.
Dandelion Energy
Series B in 2022
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.
MBX Biosciences
Series B in 2022
MBX Biosciences is a biotechnology company focused on developing therapies for endocrine and metabolic disorders, emphasizing rare endocrine diseases with limited treatment options. It pursues discovery, development, and commercialization of first-in-class peptide therapeutics that modulate glandular hormone signaling. MBX has developed a proprietary Precision Endocrine Peptide platform to engineer peptides with extended time-action profiles and consistent drug exposure, aiming to overcome limitations of traditional peptide therapies and improve disease management. Based in Carmel, Indiana, the company advances novel peptide programs through clinical development to address unmet medical needs in endocrine and metabolic disorders.
Merge simplifies secure data access by offering Unified APIs across key software categories like HRIS, accounting, CRM, and file storage. It handles the entire integration lifecycle, from initial build to maintenance, enabling thousands of companies to unblock sales, reduce churn, accelerate product launch, and save engineering resources.
Swift Navigation
Series D in 2022
Swift Navigation is a technology company that delivers precise GNSS positioning solutions for autonomous and automated systems across automotive, robotics, aerospace, agriculture, and industrial applications. Founded in 2012 and based in San Francisco with an additional location in Melbourne, Australia, the company develops hardware and software that enable centimeter-level real-time positioning through multi-band, multi-constellation RTK receivers and complementary offerings such as a ruggedized module, a positioning engine, and cloud-based corrections. Its product lineup includes Piksi Multi GNSS receivers, Duro rugged receivers, Starling positioning engine, and Skylark cloud corrections, along with related modules, antennas, radios, and cables. The end-to-end GNSS platform supports low-cost, high-accuracy positioning for autonomous vehicles, drones, robots, precision agriculture, surveying, and other industrial uses.
Theorycraft Games
Series B in 2022
Theorycraft Games operates as an independent game development studio that operates remotely. The company is in process of developing its first game codenamed Loki.
Theorycraft was founded in 2020 and is headquartered in Los Angeles, California, United States.
Allakos is a clinical-stage biopharmaceutical company developing antibody-based therapeutics targeting immunomodulatory receptors on immune effector cells. Its pipeline focuses on allergic, inflammatory, and proliferative diseases, with lead programs targeting Siglec-6 (AK006) and Siglec-8.
Higlobe
Funding Round in 2022
Founded in 2020, Higlobe is an international payment platform headquartered in Palo Alto, California. It facilitates payments for overseas freelancers and independent workers with U.S. business clients, offering zero transaction fees.
Moximed develops and provides the Atlas System, an implantable joint unloader designed to alleviate pain and preserve mobility in patients with medial compartment knee osteoarthritis. Its outpatient treatment option aims to improve quality of life for those not responsive to other therapies or candidates for knee replacement.
ZeroFOX is a cybersecurity company that provides external threat intelligence and protection against social media–based threats. It operates a cloud-based platform delivering real-time social threat analytics, protection, and monitoring to safeguard brands, people, and data across the public attack surface. Its solutions address phishing, credential compromise, impersonation, information leakage, brand hijacking, and physical or reputational risks to executives and high-profile individuals, with services including managed monitoring and protection. The company supports industries such as financial services, retail, government, healthcare, technology, education, media, and sports, and offers specialized protections for elections and high-value personnel.
Everside Health
Venture Round in 2022
Founded in 2010, Everside Health provides direct primary care services, offering convenient on-site, near-site, and virtual care options for its members. The company's data-driven approach aligns incentives to benefit patients, physicians, and benefit providers while reducing the total cost of care.
Gossamer Bio is a clinical-stage biopharmaceutical company based in San Diego that specializes in the discovery, development, and commercialization of innovative therapeutic products targeting significant unmet medical needs. Founded by former executives from Receptos, the company focuses on areas such as immunology, inflammation, fibrosis, and oncology. Its pipeline includes several promising candidates: Seralutinib, aimed at addressing pulmonary arterial hypertension; GB004, for inflammatory bowel disease; GB1275, targeting various oncology indications; and GB001, designed for moderate-to-severe eosinophilic asthma. Gossamer Bio's strategy involves leveraging a rich in-licensing environment to enhance its therapeutic offerings, supported by a team recognized for their successful track record in drug development.
QuoteWell
Series A in 2022
Founded in 2021, QuoteWell is a digital platform designed for the insurance industry. Based in Austin, Texas, it offers an integrated submission process that securely transmits insured applications to underwriters and enables agents and brokers to access modern risk transfer infrastructure.
X4 Pharmaceuticals
Post in 2022
X4 Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel oral small molecule therapeutics targeting chemokine receptor CXCR4. Its lead drug candidate, mavorixafor (X4P-001), is in Phase III trials for the treatment of WHIM syndrome and has shown promising results in other indications such as severe congenital neutropenia and clear cell renal cell carcinoma.
Narmi Inc. is a technology company that specializes in developing online and mobile banking applications for financial institutions across the United States. Founded in 2016 and headquartered in New York, Narmi provides a comprehensive platform that allows regional and community banks and credit unions to attract, engage, and retain customers effectively. The company’s applications facilitate account openings in under 2.5 minutes, while ensuring a secure and user-friendly experience through features such as fraud protection, multi-factor authentication, and transaction monitoring. In addition to banking applications, Narmi also offers services in website design, development, hosting, and content management, helping financial institutions create a dynamic and engaging digital presence.
Echodyne, established in 2014 and based in Kirkland, Washington, specializes in developing and marketing metamaterials-based radar systems. The company offers a range of radar solutions, including 3D Security radar for all-weather, compact, and solid-state sensor performance; Metamaterial Electronically Scanning Array (MESA) technology for high-performance phased-array radar at breakthrough cost levels; and Echoguard for ground-based airspace management. Additionally, Echodyne provides Acuity Software for customization and data processing, along with various deployment kits and accessories. Their products cater to commercial markets, government, defense, and industry, enabling autonomous applications in drones, vehicles, and heavy machinery, even in complex and challenging environments.
Lily AI
Venture Round in 2022
Lily AI is an innovative e-commerce product discovery platform based in Mountain View, California, that focuses on enhancing the sales performance of brands and retailers. The company specializes in integrating customer-centric product attributes into various facets of the e-commerce ecosystem, including site search engines and recommendation systems. By aligning brand messaging with customer intent, Lily AI improves on-site search, personalized product discovery, and demand prediction. This approach enables retailers, particularly in the fashion, home, and beauty sectors, to achieve significant increases in traffic, conversion rates, revenue, and brand loyalty.
Assembled
Series B in 2022
Assembled, Inc. is a workforce management platform based in San Francisco, California, founded in 2018. The company specializes in enhancing customer support operations for modern organizations by automating key processes such as contact forecasting, staffing calculations, and productivity reporting. Its platform allows teams to effectively forecast support volumes and develop appropriate staffing plans, eliminating the need for cumbersome spreadsheets and disparate internal tools. Assembled offers an intuitive team calendar that accommodates various time zones and specializations, integrating seamlessly with popular tools like Google Calendar and Slack to facilitate collaboration. Additionally, it provides visibility into support schedules and performance metrics, including response times, across all organizational levels. By streamlining these processes, Assembled empowers organizations to make informed decisions, ultimately improving their customer support capabilities.
Celcuity is a clinical-stage biotechnology company that discovers new cancer sub-types and therapeutic options using its proprietary CELsignia diagnostic platform. This platform analyzes living tumor cells to identify specific abnormal cellular processes driving cancer, enabling the development of targeted therapies for patients.
Mashgin is a California-based developer of AI-driven self-checkout kiosks used in cafeterias, convenience stores, specialty and travel retail. The system uses computer vision, deep learning, and real-time 3D technology to recognize items and handle multiple items in a single scan, speeding up checkout. The kiosks are deployed at hundreds of locations and serve tens of thousands of customers daily.
Glacier
Seed Round in 2022
Glacier develops AI-enabled recycling robots for recycling facilities. Founded in 2019 and headquartered in San Francisco, California, the company creates affordable, high-performing, and space-efficient robots that automate the sorting of recyclable materials. Its platform combines artificial intelligence-powered sensors and robotics to streamline operations, improve sorting accuracy, and increase profitability for waste facilities.
Founded in 2018, NODAR specializes in developing camera-based 3D vision systems for autonomous vehicles. Its flagship product, Hammerhead, uses off-the-shelf cameras to deliver long-range, depth-sensing capabilities, enhancing safety features like forward collision warning and automatic emergency braking.
Genies empowers individuals to create personalized digital avatars for expression across social media and messaging platforms. It offers tools for users to design avatars, avatar fashion lines, worlds, and interactive experiences, enabling brands to drive engagement through exclusive digital goods.
Trevi Therapeutics
Post in 2022
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, established in 2011. The company specializes in the development and commercialization of Haduvio, an oral extended-release formulation of nalbuphine. Haduvio is currently undergoing a Phase IIb/III clinical trial, known as the PRISM trial, aimed at treating chronic pruritus associated with prurigo nodularis. Additionally, Trevi is exploring the use of nalbuphine ER for other serious neurologically mediated conditions, including chronic cough in patients with idiopathic pulmonary fibrosis and levodopa-induced dyskinesia in individuals with Parkinson’s disease. The treatment targets conditions that share a common pathophysiology mediated through opioid receptors in the central and peripheral nervous systems.
Built Robotics
Series C in 2022
Built Robotics develops automation technology for the construction industry by turning heavy equipment into autonomous robots with AI-guided software that integrates sensors such as GPS, cameras, and Lidar. The systems retrofit onto earthmoving equipment to enable autonomous operation on job sites, supporting projects such as wind farms, oil and gas pipelines, mining, and housing developments, and they are used to automate repetitive tasks in solar projects to accelerate the transition to clean energy.
Antimatter
Series A in 2022
Antimatter is a company that provides cryptographic infrastructure services aimed at enhancing data security for B2B SaaS businesses. Founded in 2021 and located in Oakland, California, Antimatter's technology utilizes secure enclaves found in major cloud platforms to transparently encrypt customer data. This approach allows clients to adhere to stringent data security and privacy standards without necessitating any modifications to their existing code. By addressing the critical challenges of data security, Antimatter offers a solution that streamlines the protection of sensitive information for its customers.
SafeBase, Inc. is a San Francisco-based company founded in 2020 that specializes in cloud-based security software aimed at helping organizations establish and enhance their security programs. The company’s offerings include a smart trust center platform that facilitates the sharing of security posture and automates access to sensitive documents. SafeBase provides solutions such as SafeBase Inspected, which features a website badge linking to a custom security status page, as well as custom security checklists and continuous monitoring of security systems. Additionally, the software assists organizations in configuring security policies, thereby enabling them to implement robust security practices effectively.
Alfred
Venture Round in 2022
Alfred Club, Inc. is a technology-driven company that provides a resident experience and building management platform designed for apartment buildings. Founded in 2013 and based in New York, Alfred offers the Hello Alfred program, which allows residents to outsource everyday tasks such as package receiving and dog walking to dedicated home managers. These home managers are W-2 employees, ensuring they receive benefits and training, which enhances service quality and fosters local community support. The platform integrates various services, enabling residents to request assistance with grocery delivery, home cleaning, and access to exclusive events and virtual classes, all through a single, intuitive interface. Alfred has been recognized as a leader in transforming the real estate industry and has gained media attention for its innovative approach to enhancing the residential living experience.
Beyond Identity
Series C in 2022
Beyond Identity, Inc. is a New York-based company that specializes in cloud-native passwordless identity management solutions. Founded in 2019, it aims to enhance digital security by replacing traditional passwords with secure, X.509-based certificates. This innovative approach creates a robust Chain of Trust, incorporating user and device identity along with a real-time assessment of device security for adaptive authentication and authorization. Beyond Identity's platform facilitates frictionless login experiences through biometric authentication and seamless integration with Single Sign-On (SSO) systems, catering to employees, contractors, and customers alike. By eliminating the use of passwords, the company helps organizations mitigate risks associated with credential-stuffing attacks and streamline their authentication processes, ultimately enabling greater business agility and cost efficiency.
Cohere Technologies
Series D in 2022
Founded in 2010, Cohere Technologies specializes in enhancing mobile and wireless networks. Its core innovation is Orthogonal Time Frequency Space (OTFS), a novel modulation scheme designed to increase bandwidth and throughput for wireless applications.
Thunkable
Series B in 2022
Thunkable is a United States-based no-code platform that enables users to create native mobile applications without writing code. It offers a drag-and-drop interface, built-in templates, and design elements to simplify app development, with online design and instant previews on devices. The platform supports cross-platform deployment to major mobile platforms and enables direct submission to the iOS and Android app stores, allowing individuals and developers to build functional apps without traditional coding.
HackerOne
Series E in 2022
HackerOne, established in 2012 and headquartered in San Francisco, operates a platform that connects businesses with cybersecurity researchers, known as "hackers". This platform facilitates ethical hacking, where these professionals identify vulnerabilities in companies' software applications. HackerOne mediates between the hackers and the businesses, enabling secure collaboration to improve security and protect consumer data. The company's services include bug bounty solutions, vulnerability disclosure programs, and coordination processes, helping organizations reduce security risks and build trust with their customers.
FTX US Derivatives
Series A in 2022
FTX US is a bitcoin options exchange designed to assist both individual traders and institutions in trading. FTX US allows users to trade a variety of digital assets like Bitcoin, Ethereum, Solana, and Dogecoin. The company was founded by Sam Bankman-Fried and Gary Wang in 2020 and is based in San Francisco, California.
Founded in 2012, Virtru specializes in data security solutions. Its platform enables businesses to protect sensitive information throughout its lifecycle without compromising ease of use, supporting compliance and maintaining control over data.
Smartcar develops a platform that enables mobility businesses to integrate their apps with connected vehicles. Its API allows retrieval of vehicle data like location, EV charging status, and remote locking/unlocking, facilitating seamless interactions between users and their cars.
Proof of Learn
Seed Round in 2022
Proof of Learn is a Boston-based company founded in 2021 that serves as a talent marketplace for emerging developers by focusing on education, upskilling, and job placement. It operates Metacrafters.io, a multichain learn-to-earn platform designed to teach users how to write smart contracts and build on-chain applications. By leveraging blockchain technology, Proof of Learn aims to provide equal access to education and next-generation job opportunities globally. Its innovative approach enables learners to acquire skills, earn rewards, and secure employment in the evolving Web3 landscape.
Aquabyte
Venture Round in 2022
Founded in 2017, Aquabyte specializes in developing smart camera systems and machine learning models for aquaculture. Its solutions include real-time sea lice counting, biomass monitoring, appetite detection, and feed optimization, aiming to enhance fish farm efficiency, sustainability, and profitability.
Korro Bio
Series B in 2022
Korro Bio Inc., established in 2018 and headquartered in Cambridge, Massachusetts, specializes in developing nucleic acid-based therapeutics targeting specific sequences in genetic code to treat rare diseases. The company's proprietary platform enables efficient and selective RNA editing, leveraging natural processes common to all multicellular organisms. Korro Bio aims to advance this technology to effect changes in protein structure and function across multiple tissues, expanding the reach of genetic medicines with additional precision and tunability by editing RNA instead of DNA.
Mojo Vision
Series B in 2022
Founded in 2015, Mojo Vision specializes in developing and commercializing advanced micro-LED display technology for various applications. The company is renowned for creating the world's smallest dynamic display for augmented reality smart contact lenses. Headquartered in Saratoga, California, Mojo Vision aims to disrupt the $160 billion display industry with its proprietary quantum-dot technology.
Sorriso Pharmaceuticals
Series A in 2021
Founded in 2020 and headquartered in San Diego, California, Sorriso Pharmaceuticals is a biotechnology company dedicated to developing disease-modifying antibodies for treating inflammatory diseases such as Crohn's disease and ulcerative colitis. Its proprietary platform generates potent antibodies designed for oral delivery, aiming to maintain therapeutic activity throughout the intestinal system.
Pair Eyewear
Series B in 2021
Pair Eyewear, Inc. is a New York-based company that specializes in customizable eyeglasses for children. Founded in 2017 by Nathan Kondamuri and Sophia Edelstein, the company offers a unique approach to eyewear by providing base frames and interchangeable top frames that allow kids to express their personal style and interests. By combining functionality with creativity, Pair Eyewear transforms glasses from mere medical devices into a fun and engaging accessory for children. The company's direct-to-consumer model leverages an e-commerce platform, making the purchasing process convenient for parents while enhancing the overall experience for young wearers. Pair Eyewear is committed to offering quality, affordable glasses that are both stylish and practical, featuring hand-polished frames and shatterproof polycarbonate lenses.
Anyscale develops and operates distributed programming platforms for simplifying distributed AI development. It offers Ray, an open-source framework enabling software developers and machine learning engineers to scale applications effortlessly from a laptop to the cloud.
Regulus Therapeutics
Post in 2021
Regulus Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of microRNA-targeted therapies for various diseases. Founded in 2007 and headquartered in San Diego, California, the company focuses on innovative treatments for conditions such as kidney diseases and viral infections. Its lead product candidates include RG-012, an anti-miR targeting miR-21, currently in Phase II clinical trials for Alport syndrome, and RGLS4326, an anti-miR targeting miR-17, which is undergoing Phase Ib clinical trials for autosomal dominant polycystic kidney disease. Additionally, Regulus is advancing a pipeline of preclinical drug candidates, including RGLS5579 to inhibit miR-10b, as well as programs aimed at treating Hepatitis B virus and Non-Alcoholic Steatohepatitis. The company's work leverages the recent scientific advancements in microRNA research, which play a crucial role in regulating gene expression.
Merge simplifies secure data access by offering Unified APIs across key software categories like HRIS, accounting, CRM, and file storage. It handles the entire integration lifecycle, from initial build to maintenance, enabling thousands of companies to unblock sales, reduce churn, accelerate product launch, and save engineering resources.
Contra is a networking platform founded in 2019 by Ben Huffman and Gajus Kuizinas. It connects independent professionals with flexible work opportunities through an exclusive community, enabling freelancers to earn a living on their own terms.
Kiswe
Venture Round in 2021
Kiswe specializes in enhancing live event viewing by connecting at-home audiences with in-venue fans through interactive video experiences. Its cloud-based Kiswe Studio transforms professional event production and broadcasting. Serving global broadcasters, sports leagues, and music labels like Big Hit Entertainment (BTS), NBA, Globo, MLS, PGA Tour, and Turner Sports.
Attest Technologies Ltd., established in 2015 and headquartered in London, UK, operates a global online consumer research platform. It offers businesses real-time, on-demand consumer insights through surveys, enabling them to make data-driven decisions across various aspects such as marketing, product development, and brand tracking. Attest's platform allows direct engagement with over 110 million consumers across 45 countries, providing international research and testing solutions. The company is backed by prominent investors, including NEA, and serves clients aiming to drive predictable growth and fill knowledge gaps.
Stride Health
Series C in 2021
Stride Health, Inc. is a health benefits platform that specializes in providing affordable health coverage options for independent workers and part-time employees in the United States. The company offers a range of services, including dental plans, doctor and prescription insurance plans, and various health coverage options tailored to meet the needs of its customers. Stride Health simplifies the enrollment process by guiding users through selecting the most cost-effective health plans, aiming to optimize their tax benefits and enhance their take-home pay. Founded in 2013 and based in San Francisco, California, the company was previously known as Covered, Inc. and rebranded to Stride Health, Inc. in March 2013. Stride Health also provides personal advisory services to assist clients in navigating the complexities of their health insurance options.
Founded in 2013, Clarifai specializes in advanced image recognition systems for detecting near-duplicates and enabling visual search. Its platform recognizes various categories, objects, and tags in images, and finds similar images in large uncategorized repositories using a combination of semantic and visual similarity.
Founded in 2021, Wizard is a New York-based software company specializing in B2B solutions. It leverages conversational AI technology to enable brands to sell and market products directly through text messaging, enhancing customer engagement and conversion rates.
Slope.io, Inc. is a company that specializes in clinical trial logistics, catering to sponsors, contract research organizations (CROs), and research sites throughout the United States. Founded in 2016 and based in Mobile, Alabama, Slope.io offers a platform that streamlines the operational complexities associated with clinical trials. Its Slope.io Coordination service converts logistics requirements into organized schedules and workflows, while the Slope.io Kitting service provides customizable supply kits tailored to specific sites, patients, or study time points. The company emphasizes real-time coordination and complete traceability of devices, drugs, and kits from suppliers to research sites and patients.
IonQ is a quantum computing company that develops general-purpose quantum information processors based on trapped-ion technology. Its approach enables qubit replication, optical networkability, and optimized algorithms to support scalable quantum computation beyond classical capabilities. Founded in 2015 and based in College Park, Maryland, IonQ offers access to its quantum computers through cloud platforms, providing quantum-computing-as-a-service to a broad user base and select customers through its own cloud service. Revenue streams include QCaaS arrangements and related consulting and co-development contracts for algorithm design and system integration.
Pager, Inc. is a company that operates an on-demand service platform designed to connect patients with healthcare services in various settings including homes, offices, and hotels. The company offers a mobile application that facilitates access to urgent care for a range of conditions such as infections, respiratory issues, and allergies. In addition to its core services, Pager provides nurse chat, teleconsultation, screening, vaccination, and prescription delivery. The company's mission focuses on improving healthcare accessibility, lowering costs, and simplifying care navigation through a flexible platform that integrates artificial intelligence and service teams. Amidst its extensive offerings, Pager supports over 15 million individuals across the United States and Latin America, enabling coordinated care that enhances patient engagement and decision-making. Incorporated in 2013 and headquartered in New York, Pager was previously known as techCare, Inc. before rebranding in 2014.
Allay Therapeutics
Series C in 2021
Allay Therapeutics is pioneering ultra-sustained pain therapeutics to transform post-surgical pain management. Its proprietary platform combines non-opioid analgesics and biopolymers to create dissolvable therapeutics delivering pain relief within targeted sites over weeks, significantly longer than current treatments. The company's lead product candidate, ATX101, is in Phase 2 clinical trials for total knee replacement surgeries.
Databricks
Series H in 2021
Databricks offers a unified data analytics platform that simplifies data integration, enables real-time experimentation, and facilitates robust deployment of production applications for developers and data scientists. Serving diverse industries worldwide, Databricks' platform supports collaborative data science, machine learning workflows, and integrates with various cloud services.
Rapid Robotics
Series B in 2021
Rapid Robotics is a provider of industrial automation solutions focused on robotic arms and palletizing systems for manufacturing and logistics. The company develops and deploys affordable robotic workcells and software that combine AI and vision-based capabilities to handle a range of palletizing and material-handling tasks. Its offerings enable rapid deployment, often in hours rather than weeks, and aim to lower operating costs while increasing production capacity, efficiency, and quality. Through a Robot-as-a-Service model, Rapid Robotics helps sites scale automation without the burden of ownership or extensive custom programming. Founded in 2019 and headquartered in San Francisco, the company targets manufacturers facing labor shortages and rising fulfillment complexity by delivering flexible, service-driven automation that improves margins and throughput.
Airspan Networks
Post in 2021
Airspan Networks is a global provider of 4G broadband wireless systems and solutions. Established in 1992, the company delivers high-speed data, voice, and multimedia services to operators and vertical markets worldwide, serving over 500 operators across licensed and unlicensed frequency bands up to 6GHz. Its comprehensive product range includes indoor/outdoor small cells, open RAN base stations, fixed wireless access solutions, and related design services.
Tulip Interfaces
Series C in 2021
Tulip Interfaces is a technology company that creates shop‑floor applications for the manufacturing sector. Its no‑code platform integrates sensor data, digital work instructions, real‑time visualization, and operator inputs to connect existing equipment and streamline operations. The solution is used by firms in consumer electronics, pharmaceuticals, apparel, medical devices, aerospace, defense, automotive, and contract manufacturing to improve productivity, quality, and operational visibility. Founded in 2012, the company is headquartered in Somerville, Massachusetts.
Berkshire Grey
Post in 2021
Berkshire Grey, Inc. is a technology company specializing in the development of artificial intelligence-driven robotic and automated material handling systems. Founded in 2013 and based in Lexington, Massachusetts, the company focuses on automating tasks traditionally performed by humans in commercial settings, enhancing efficiency in fulfillment, supply chain, and logistics operations. Its offerings include a range of robotic solutions, such as autonomous picking and sorting systems, mobile robotic units, and dynamic parcel sortation technologies. Additionally, Berkshire Grey provides electromechanical solutions that incorporate vision systems and advanced scanning technologies. By leveraging AI, computer vision, and machine learning, the company's systems enable clients to achieve higher accuracy and throughput speeds while managing diverse product assortments. The majority of its revenue is generated from North America, positioning Berkshire Grey as a significant player in the automation landscape.
Shape Therapeutics
Series B in 2021
Shape Therapeutics, Inc. is a biotechnology company focused on RNA-editing gene therapy for various medical conditions, including neurodegenerative disorders, oncology, metabolic diseases, and rare genetic disorders. Founded in 2018 and headquartered in Seattle, Washington, the company utilizes its proprietary RNAfix technology to edit RNA using the body’s natural cellular machinery. This approach minimizes risks associated with immunogenicity, cellular toxicity, and unintended DNA editing. Shape Therapeutics is dedicated to advancing its innovative platforms for payload, delivery, and manufacturing to enable the development of effective treatments, aiming to address critical health challenges and improve patient outcomes.